StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report issued on Tuesday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Up 3.2 %
Shares of NYSE:CPHI opened at $0.27 on Tuesday. The company has a current ratio of 0.89, a quick ratio of 0.25 and a debt-to-equity ratio of 0.17. China Pharma has a 52-week low of $0.24 and a 52-week high of $1.95. The firm has a fifty day moving average of $0.28 and a 200 day moving average of $0.37.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $1.37 million for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Recommended Stories
- Five stocks we like better than China Pharma
- Stock Average Calculator
- Sales Breakout Sends This Semiconductor Stock to Record High
- Earnings Per Share Calculator: How to Calculate EPS
- Surprise Buying Opportunity on This Dividend Aristocrat
- Find and Profitably Trade Stocks at 52-Week Lows
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
